PLoS ONE:对精液mRNA及MicroRNA的研究

2012-04-14 Deepblue 生物谷

无细胞(cell-free)的mRNA及microRNA (miRNA)能够作为临床应用的分子标记物以及胞内通讯的信号分子,都是关于它们的物理性质的研究还很缺乏。近日,华中科技大学同济医学院的研究人员研究对人类无细胞的精液mRNA(cfs-mRNA)及miRNA(cfs-miRNA)开展了一项有特别意义的研究。 在该实验中,精液特异的mRNAs、miRNAs及piRNAs在所有的实验中被实时定量

无细胞(cell-free)的mRNA及microRNA (miRNA)能够作为临床应用的分子标记物以及胞内通讯的信号分子,都是关于它们的物理性质的研究还很缺乏。近日,华中科技大学同济医学院的研究人员研究对人类无细胞的精液mRNA(cfs-mRNA)及miRNA(cfs-miRNA)开展了一项有特别意义的研究。

在该实验中,精液特异的mRNAs、miRNAs及piRNAs在所有的实验中被实时定量PCR检测。

研究人员发现,虽然通过time-course分析表明,cfs-miRNA的稳定性与cfs-mRNA相似,但是对精浆采用过滤及Triton X-100处理后,cfs-miRNA及cfs-mRNA总量的变化特征却是不同的,这暗示了它们可能有不同的物理性质。随后,精液的超微小泡(SMVs)被恢复,SMVs中的cfs-mRNA及cfs-miRNA的含量也被定量。

SMVs内的cfs-mRNAs的含量几乎与其重量一致,并且在不同大小的SMVs中高度可变。而大多数的cfs-miRNA则独立于SMVs存在于上层清液。

通过对上层清液过滤及蛋白酶K的消化,进一步研究cfs-miRNA。实验中,cfs-miRNA通过了0.10μm大小的孔,但是在强烈的蛋白酶K的消化后被显著降解。

结果表明,cfs-mRNA主要存在于SMVs内,而大部分的cfs-miRNA结合于蛋白复合体。

该研究阐明了人类精液中细胞外RNAs的稳定性,表明了它们的来源及在男性繁殖中潜在的功能,也为发展它们作为男性生殖系统生物标记物提供了新的策略。相关论文发表在4月10日的PLoS ONE。(生物谷Deepblue编译)

doi: 10.1371/journal.pone.0034566
PMC:
PMID:

Cell-Free Seminal mRNA and MicroRNA Exist in Different Forms

Honggang Li, Shiyun Huang, Cuicui Guo, Huangtao Guan, Chengliang Xiong.

The great interest in cell-free mRNA, microRNA (miRNA) as molecular biomarkers for clinical applications, and as ‘signaling’ molecules for intercellular communication highlights the need to reveal their physical nature. Here this issue was explored in human cell-free seminal mRNA (cfs-mRNA) and miRNA (cfs-miRNA).Selected male reproductive organ-specific mRNAs, miRNAs, and piRNAs were quantified by quantitative real-time PCR in all experiments.While the stability of cfs-miRNA assessed by time-course analysis (up to 24 h at room temperature) was similar with cfs-mRNA, the reductive changes between cfs-miRNA and cfs-mRNA after filtration and Triton X-100 treatment on seminal plasma were very different, implying their different physical nature. Seminal microvesicles (SMVs) were then recovered and proportions of cfs-mRNA and cfs-miRNA within SMVs were quantified.The amounts of SMVs- sequestered cfs-mRNAs almost were the same as total cfs-mRNA, and were highly variable depending on the different sizes of SMVs. But most of cfs-miRNA was independent of SMVs and existed in the supernatant.The possible form of cfs-miRNA in the supernatant was further explored by filtration and protease K digestion. It passed through the 0.10-μm pore, but was degraded dramatically after intense protease K digestion.The predominant cfs-mRNA is contained in SMVs, while most cfs-miRNA is bound with protein complexes.Our data explained the stability of extracellular RNAs in human semen, and shed light on their origins and potential functions in male reproduction, and strategy of developing them as biomarkers of male reproductive system.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1857280, encodeId=947f185e2801f, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 01 23:32:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084067, encodeId=3bef208406eb2, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 14 14:32:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789409, encodeId=4ed91e89409de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Mar 23 21:32:00 CST 2013, time=2013-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296522, encodeId=5d671296522e6, content=<a href='/topic/show?id=efe0e645817' target=_blank style='color:#2F92EE;'>#精液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76458, encryptionId=efe0e645817, topicName=精液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435644, encodeId=f575143564479, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1857280, encodeId=947f185e2801f, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 01 23:32:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084067, encodeId=3bef208406eb2, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 14 14:32:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789409, encodeId=4ed91e89409de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Mar 23 21:32:00 CST 2013, time=2013-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296522, encodeId=5d671296522e6, content=<a href='/topic/show?id=efe0e645817' target=_blank style='color:#2F92EE;'>#精液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76458, encryptionId=efe0e645817, topicName=精液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435644, encodeId=f575143564479, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-08-14 xjy02
  3. [GetPortalCommentsPageByObjectIdResponse(id=1857280, encodeId=947f185e2801f, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 01 23:32:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084067, encodeId=3bef208406eb2, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 14 14:32:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789409, encodeId=4ed91e89409de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Mar 23 21:32:00 CST 2013, time=2013-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296522, encodeId=5d671296522e6, content=<a href='/topic/show?id=efe0e645817' target=_blank style='color:#2F92EE;'>#精液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76458, encryptionId=efe0e645817, topicName=精液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435644, encodeId=f575143564479, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1857280, encodeId=947f185e2801f, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 01 23:32:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084067, encodeId=3bef208406eb2, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 14 14:32:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789409, encodeId=4ed91e89409de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Mar 23 21:32:00 CST 2013, time=2013-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296522, encodeId=5d671296522e6, content=<a href='/topic/show?id=efe0e645817' target=_blank style='color:#2F92EE;'>#精液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76458, encryptionId=efe0e645817, topicName=精液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435644, encodeId=f575143564479, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-04-15 hb2008ye
  5. [GetPortalCommentsPageByObjectIdResponse(id=1857280, encodeId=947f185e2801f, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jul 01 23:32:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2084067, encodeId=3bef208406eb2, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Aug 14 14:32:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789409, encodeId=4ed91e89409de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Mar 23 21:32:00 CST 2013, time=2013-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296522, encodeId=5d671296522e6, content=<a href='/topic/show?id=efe0e645817' target=_blank style='color:#2F92EE;'>#精液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76458, encryptionId=efe0e645817, topicName=精液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435644, encodeId=f575143564479, content=<a href='/topic/show?id=31df11e1642' target=_blank style='color:#2F92EE;'>#microRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11716, encryptionId=31df11e1642, topicName=microRNA)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-04-15 zhouqu_8

相关资讯

2012年01-02月 Nature亮点研究汇总

2012年01—2012年02月Nature亮点研究整理版 大脑对奖励的反应 Neuron-type-specific signals for reward and punishment in the ventral tegmental area 1月18日,美国物理学家组织网报道,美国科学家绘制出了迄今最完整的大脑神经相互作用以增强从学习到服药等行为的图谱,有望为科学家们治疗成瘾开辟新道路

Mol Cell:研究人员找出炎症反应关键调节因子

近日,美国波士顿大学医学院(BUSM)研究人员已经发现一种基因在调节炎症反应和内环境稳态中起着关键作用。这些发现可能有助于开发出减少癌症、2型糖尿病和其他疾病相关的炎症。   BUSM生物化学助理教授Valentina Perissi博士带领的研究团队与圣迭戈加利福尼亚大学霍华德·休斯医学研究所(HHMI)合作共同完成该项研究。研究结果发表在Molecular Cell杂志上。 &

AJKD:单次测量基线蛋白尿 肾脏不良预后风险易低估

近日,《美国肾脏病杂志》(American Journal of  Kidney Diseases)发表了加拿大阿尔伯塔大学医院研究人员的研究结果,单次测量基线蛋白尿易低估肾脏不良预后风险。 研究者在加拿大阿尔伯塔省开展纵向研究,测试入组成年人的蛋白尿水平(试纸测量)、计算尿白蛋白/肌酐比值(Albumin creatinine ratio,ACR)。记录受试者的全因死亡率、终末期肾脏

Science:一种防止前吸毒成瘾者复吸不用药的方法

4月13日,国际著名杂志Science在线刊登了北京大学研究人员的最新研究成果“A Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse,”,文章中,研究者提出了一个防止前吸毒成瘾者复吸的不用药的方法。对大鼠和人的志愿者所做的新的研究提出了一个可帮助前吸毒成瘾者避免复吸的策略。该方法涉及到修改一个人对过去

J Nati Cancer I:麦海强等鼻咽癌研究取得新进展

近日,国际著名杂志Journal of the National Cancer Institute 刊登了中山大学肿瘤防治中心鼻咽科麦海强教授等的最新研究成果“Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial。”在文章

Journal Watch 2011心脏病热门研究

  近日,《新英格兰医学杂志》旗下的Journal Watch网站公布了由编辑挑选的2011心脏病热门研究。   包括:   1、缺血性左室收缩功能不全患者CABG或药物治疗   冠状动脉旁路移植术(CABG)或可在某种程度减少缺血性左室收缩功能不全(LVSD)患者的不良转归,但并未延长生命。   2、经导管主动脉瓣置入:高危手术的理想替代选择?   经导管主动脉瓣置入(TAVI)在短期